BCOR and sarcoma: Conversely, the HG group has a very poor prognosis, and as they grouped together with the BCOR–CCNB3 positive samples (so called “Ewing-like” sarcomas) from the control cohort, describing a very-well defined cluster, the therapeutic strategy should be discussed, both in the adjuvant and the metastatic setting, with potentially a more intensive multiagent chemotherapy regimen.